GE HealthCare Thailand
GE HealthCare Thailand is the Thai subsidiary of GE HealthCare Technologies (NASDAQ: GEHC, 2023 spinoff from General Electric). ~8% of Thai medical-device market value. Portfolio: CT, MRI, ultrasound, X-ray, patient monitoring, anesthesia, life-support, pharmaceutical diagnostics (contrast media). Direct competitor to Siemens Healthineers, Philips.
Snapshot
Headline numbers a buyer checks first.
Thai market share
~8% by value
FY2024
Parent
GE HealthCare (NASDAQ: GEHC)
2023 spinoff
Portfolio
Imaging, ultrasound, monitoring
FY2024
Status
Private Thai subsidiary
Ongoing
What this subsidiary actually does
GE HealthCare Thailand imports, installs, and services imaging, monitoring equipment. Portfolio strengths: ultrasound (Voluson, Logiq), CT (Revolution series), MRI (Signa series), patient monitoring (Carescape), anesthesia (Aisys CS). Customer base spans major Thai hospital systems, diagnostic centres, private clinics. Post-2023 spinoff from GE, operating focus has sharpened on core imaging, monitoring; pharmaceutical diagnostics adds contrast-media franchise.[]
Competitive position: #2 or #3 position in Thai imaging after Siemens Healthineers; strong in ultrasound, patient-monitoring. Post-spinoff capital, pipeline flexibility supports growth. Challenges: private-hospital capex cycle variability, public-procurement competitive tender pressure.[]
Product portfolio segments
Imaging
CT, MRI, and X-ray systems
Revolution CT series and Signa MRI systems are installed across Thailand's top private and public hospital groups. GE holds a #2 or #3 position in CT and MRI behind Siemens Healthineers, competing on service infrastructure.
Ultrasound
Voluson and Logiq ultrasound
Among the strongest positions in the Thai ultrasound market. Voluson (obstetrics) and Logiq (general, point-of-care) lines serve private clinics, district hospitals, and specialist centres across all 77 provinces.
Monitoring
Carescape patient monitoring
Carescape patient monitors and Aisys anesthesia machines are deployed across Thai ICUs, operating theatres, and emergency departments. Integration with hospital information systems (HIS) is a competitive differentiator.
Diagnostics
Pharmaceutical diagnostics
Post-2023 GE spinoff, the pharmaceutical-diagnostics (contrast media) franchise remains within GEHC. Omnipaque and Visipaque contrast agents are distributed through Thai hospital pharmacy channels.
Thai medical imaging — MNC peer comparison
Major MNC medical-device subsidiaries in Thailand, FY2024 market-share estimates
Parent listing
ETR:SHL
Thai mkt share (est.)
Key specialty
CT, MRI, IVD
Imaging rank (est.)
#1 imaging
Parent listing
NASDAQ:GEHC
Thai mkt share (est.)
Key specialty
CT, ultrasound, monitoring
Imaging rank (est.)
#2-3 imaging
Parent listing
AMS:PHI
Thai mkt share (est.)
~7%
Key specialty
Ultrasound, monitoring, MRI
Imaging rank (est.)
#3 imaging
Parent listing
NYSE:MDT
Thai mkt share (est.)
~9%
Key specialty
Cardiac, surgical, diabetes
Imaging rank (est.)
Surgical leader
Parent listing
NYSE:ABT
Thai mkt share (est.)
~6%
Key specialty
IVD, cardiovascular, diabetes
Imaging rank (est.)
IVD, diabetes
| Company | Parent listing | Thai mkt share (est.) | Key specialty | Imaging rank (est.) |
|---|---|---|---|---|
| Siemens Healthineers Thailand | ETR:SHL | ~12% | CT, MRI, IVD | #1 imaging |
| GE HealthCare Thailand | NASDAQ:GEHC | ~8% | CT, ultrasound, monitoring | #2-3 imaging |
| Philips Thailand | AMS:PHI | ~7% | Ultrasound, monitoring, MRI | #3 imaging |
| Medtronic Thailand | NYSE:MDT | ~9% | Cardiac, surgical, diabetes | Surgical leader |
| Abbott Thailand | NYSE:ABT | ~6% | IVD, cardiovascular, diabetes | IVD, diabetes |
Watchpoints 2025-2026
Competitive
Siemens Healthineers CT-MRI competition
Siemens holds the leading imaging position in Thailand. GE's CT and MRI competitive positioning depends on post-spinoff GEHC R&D pipeline and Thailand's public-procurement tender pricing.
Market demand
Private hospital capex cycle
Thailand's private-hospital capex cycle (BDMS, BNH, Bumrungrad expansion programmes) drives high-value equipment replacement demand. Public hospital procurement under NHSO and the 20-year National Health Plan are the secondary volume driver.
Strategic
Post-spinoff GEHC capital allocation
GEHC's 2023 spinoff from GE allows dedicated capital allocation to healthcare. Thailand's emerging-market positioning in GEHC's Asia-Pacific strategy determines future service infrastructure investment and product-line prioritisation.
Related Market profiles
Peers, parents, partners, agencies, and other Medical Devices actors.
Competitor
Siemens Healthineers Thailand
Direct imaging, IVD leader competitor.
Open Market profile →
Competitor
Philips Thailand
Direct imaging, monitoring competitor.
Open Market profile →
Sector peer
Abbott Thailand
US-parent MNC diagnostics, CGM, nutrition, cardiovascular; FreeStyle Libre anchor; ~6% Thai medical-device market share.
Open Market profile →
Sector peer
Becton Dickinson Thailand (BD Thailand)
Thai subsidiary of Becton Dickinson (NYSE: BDX); distributes and markets BD's medical devices, diagnostics, and life-science products across the Thai healthcare market.
Open Market profile →
Sources + data provenance
Every filing, filing-adjacent register, or trusted industry source cited in this profile.
GE HealthCare Thailand — Subsidiary Disclosures
| Source | Publisher | Grade | As of |
|---|---|---|---|
| GE HealthCare Thailand — Subsidiary Disclosures | GE HealthCare Thailand | Well established | 2025-12-31 |